ClinicalTrials.Veeva

Menu

Impact of Fourier Transform Infrared Spectroscopy (FTIRS) in ICUs (ECLA'IR)

C

Caen University Hospital

Status

Enrolling

Conditions

Organ Failure, Multiple

Treatments

Diagnostic Test: FTIR results

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study will assess the impact of FTIRS typing on the spread of ESBL-E in intensive care units

Full description

Multidrug resistant enterobacterales (MDR-E) are a major threat for patients hospitalized in intensive care units (ICUs). To prevent MDR-E spread in ICUs, rectal swabs are routinely performed and cultured on selective media. However, bacterial identification and antimicrobial susceptibility results are not sufficient to diagnose cross transmissions. The gold standard technique is based on genomic analysis that require whole genome sequencing (WGS) of bacteria and followed by multilocus sequence typing (MLST) and Single Nucleotide Polymorphism (SNP) typing. This technology is rather expensive and not applicable in all centers.

Fourier Transform InfraRed Spectroscopy (FTIRS) is a developing method for rapid bacterial typing. This technology is simple and results can be obtained in one hour. It is therefore adapted to continuous surveillance of MDR-E. In France, extended spectrum betalactamase producing enterobacteriaceae (ESBL-E) represent the vast majority of MDR-E. We postulate that early diagnosis of cross-transmission by FTIRS may prevent the spread of ESBL-E in ICUs and favor compliance with hygiene measures. The aim of this study will be to assess the impact of systematic FTIRS typing of ESBL-E on ESBL-E cross-transmissions in ICUs.

Enrollment

900 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients hospitalized in ICU
  • ESBL-E carrier

Exclusion criteria

  • none

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

900 participants in 2 patient groups

Standard care
No Intervention group
Description:
Standard care are defined by routine procedures implemented in each center to prevent and control the diffusion of MDR-E bacteria in ICUs. In the first period of the study, the frequency of cross transmission will be assessed by sequencing the first ESBL-E isolate in each carrier patients (first isolate of a given species)
Transmission of FTIR results
Experimental group
Description:
In second phase of the study, the result of FTIR typing of recovered ESBL-E isolates will be weekly transmitted to participating centers.
Treatment:
Diagnostic Test: FTIR results

Trial contacts and locations

1

Loading...

Central trial contact

Camille Jeanne-Leroyer; Olivier Join-Lambert, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems